Guardant Health, Inc. (GH)

Guardant Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	563.95	449.54	373.65	286.73	214.38
Revenue Growth (YoY)	25.45%	20.31%	30.32%	33.75%	136.52%
Cost of Revenue	227.05	156.33	122.91	92.54	70.72
Gross Profit	336.9	293.21	250.74	194.2	143.66
Selling, General & Admin	451.03	463.78	398.52	299.28	139.73
Research & Development	367.19	373.81	263.22	149.86	86.29
Other Operating Expenses	83.4	0	0	0	0
Operating Expenses	901.62	837.59	661.74	449.15	226.03
Operating Income	-564.73	-544.38	-411	-254.95	-82.37
Interest Expense / Income	2.58	2.58	2.58	4.77	1.18
Other Expense / Income	-88.54	106.49	-8.21	-6.31	-6.03
Pretax Income	-478.76	-653.45	-405.37	-253.4	-77.52
Income Tax	0.69	1.14	0.3	0.38	-1.87
Net Income	-479.45	-654.59	-405.67	-253.78	-75.65
Shares Outstanding (Basic)	112	102	101	98	91
Shares Outstanding (Diluted)	112	102	101	98	91
Shares Change	9.60%	0.85%	3.91%	7.62%	197.99%
EPS (Basic)	-4.28	-6.41	-4.00	-2.60	-0.84
EPS (Diluted)	-4.28	-6.41	-4.00	-2.60	-0.84
Free Cash Flow	-345.46	-386.92	-284.05	-157.99	-68.35
Free Cash Flow Per Share	-3.08	-3.79	-2.80	-1.62	-0.75
Gross Margin	59.74%	65.23%	67.11%	67.73%	67.01%
Operating Margin	-100.14%	-121.10%	-110.00%	-88.92%	-38.42%
Profit Margin	-85.02%	-145.61%	-108.57%	-88.51%	-35.29%
Free Cash Flow Margin	-61.26%	-86.07%	-76.02%	-55.10%	-31.88%
EBITDA	-433.31	-614.91	-380.52	-227.01	-60.52
EBITDA Margin	-76.83%	-136.79%	-101.84%	-79.17%	-28.23%
Depreciation & Amortization	42.88	35.96	22.27	21.63	15.82
EBIT	-476.19	-650.87	-402.79	-248.64	-76.34
EBIT Margin	-84.44%	-144.79%	-107.80%	-86.72%	-35.61%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).